In conclusion, shorter application of invasive ventilation during neonatal intensive care unit (NICU) care (less than 49 days) and ROP treatment via anti-VEGF injection have emerged as controllable factors that might improve ophthalmic prognosis among neonates treated for ROP. The gene discussed is VEGFA; the disease is retinopathy of prematurity.